The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery - 17/10/19
Abstract |
Background |
The present study aimed to evaluate safety of tranexamic acid (TA) administration and to assess bleeding risk in colorectal surgery (CRS).
Methods |
Retrospective cohort study including consecutive patients undergoing elective CRS by a single surgeon between August 2014 and May 2015. All patients received 1 g of TA intravenously at induction and at closure. Demographics, operative and postoperative details were prospectively assessed and compared to a historical control cohort.
Results |
213 patients were evaluated. TA did not increase complications, readmissions, or reoperation rates. Significant postoperative hemoglobin (Hgb) drop (≥3 g/dL) (TA: n = 6, 7.4%, Control: n = 22, 16.6%; p = 0.193) and transfusion rates (intraoperative: TA: n = 2, 2.5%, Control: n = 2, 1.5%; p = 0.586, postoperative: TA: n = 1, 1.2%, Control: 9, 6.8%; p = 0.065) were not statistically different.
Conclusions |
Postoperative hemoglobin drop and transfusion rates were not decreased statistically. Further study is warranted given the large clinical differences in favor of TA.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Use of tranexamic acid (TA) has not yet been assessed for colorectal surgery. |
• | TA administration did not increase complications, readmissions or reoperations. |
• | Postoperative hemoglobin drop and transfusion rate were not decreased statistically. |
• | Large clinical differences in favor of TA warrant further study. |
Résumé |
Tranexamic acid (TA) administration did not increase complications, readmissions or reoperations in this consecutive, unselected cohort of colorectal surgical patients. Postoperative hemoglobin drop and transfusion rate were not decreased statistically; however, large clinical differences in favor of TA warrant further study.
Le texte complet de cet article est disponible en PDF.Keywords : Tranexamic acid, Colorectal surgery, Patient outcomes
Plan
Vol 218 - N° 5
P. 876-880 - novembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?